Lexaria Bioscience

North America Legal Chronicle. October 11, 2023

Lexaria Bioscience Corp.’s $1.6 Million Common Stock Offering

By Leila Ahmed

Sichenzia Ross Ference Carmel represented Lexaria Bioscience Corp. on the offering, and Ellenoff Grossman & Schole represented Maxim Group LLC. Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (“Lexaria” or...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. May 17, 2023

Lexaria Bioscience Corp.’s $2.0 Million Public Offering

By Leila Ahmed

Sichenzia Ross Ference LLP represented Lexaria Bioscience Corp. on the deal. Lexaria Bioscience Corp., (NASDAQ: “LEXX”), a global innovator in drug delivery platforms, announced a $2.0 million...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Amcor’s $37 Billion Merger with Berry Global

SBL Holdings’ $650 Million Senior Notes Offering

Huntington’s $1.75 Billion Notes Offering

GSK’s Acquisition of CMG1A46 from Chimagen Biosciences

YPF Luz’s US$420 Million Notes Issuance

360 Energy Solar’s US$22 Million Green Notes Issuance

Vier Gas Transport’s €500 Million Bond Issuance

Kerry Co-Operative Creameries’ Acquisition of Kerry Dairy Ireland

Helarb Group’s Acquisition of Pantucci Thermolaquage SA

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Lulu Retail Holdings Plc’s $1.72 Billion IPO On ADX

NBL and LK Group’s Investment in WNBL

Vietcombank’s Acquisition of Construction Bank

AGC Automotive (Thailand) Co., Ltd. v. Renewable Energy for Thai People Co., Ltd.

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Leading Healthcare and Life Sciences Attorney Craig Bleifer Joins McGuireWoods

Hogan Lovells Bolsters International Arbitration Practice with Strategic Hire of Rob Palmer in Singapore

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Leading Healthcare and Life Sciences Attorney Craig Bleifer Joins McGuireWoods

Hogan Lovells Bolsters International Arbitration Practice with Strategic Hire of Rob Palmer in Singapore

Lexaria Bioscience Corp.’s $1.6 Million Common Stock Offering

Standard 1 Year Membership Required

Lexaria Bioscience Corp.’s $2.0 Million Public Offering

Standard 1 Year Membership Required